Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $33.64 USD
Change Today +1.89 / 5.95%
Volume 2.8M
MDCO On Other Exchanges
Symbol
Exchange
Munich
NASDAQ GS
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - MEDICINES COMPANY (MDCO)

The Medicines Company to Report Q2, 2015 on Jul 29, 2015
CapIQ 07/29/2015 12:30 PM ET
The Medicines Company to Report Q1, 2015 on May 05, 2015
CapIQ 07/29/2015 12:30 PM ET
The Medicines Company to Report Q4, 2014 on Feb 18, 2015
CapIQ 07/29/2015 12:30 PM ET

2013 revenues at The Medicines Company totaled $687.9M USD, while annual earnings equaled $1.50 per share.

Quarterly Earnings & Estimates - MEDICINES COMPANY (MDCO)

Actuals vs. Estimates for MEDICINES COMPANY MDCO

The Medicines Company's Quarterly Earnings

The Medicines Company reported 2nd quarter 2014 earnings of $0.31 per share on 07/25/2014.

Annual Earnings & Estimates - MEDICINES COMPANY (MDCO)

Actuals vs. Estimates for MEDICINES COMPANY MDCO

The Medicines Company's Annual Earnings

The Medicines Company reported annual 2013 earnings of $1.50 per share on 02/21/2014.

Quarterly Revenues - MEDICINES COMPANY (MDCO)

Actuals vs. Estimates for MEDICINES COMPANY MDCO

The Medicines Company's Quarterly Revenues

The Medicines Company had 2nd quarter 2014 revenues of $183.8M USD. This missed the $184.1M USD consensus estimate of the 9 analysts following the company. This was 6.3% above the prior year's 2nd quarter results.

Annual Revenues - MEDICINES COMPANY (MDCO)

Actuals vs. Estimates for MEDICINES COMPANY MDCO

The Medicines Company's Annual Revenues

The Medicines Company had revenues for the full year 2013 of $687.9M USD. This was 23.1% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $33.64 USD +1.89

MDCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BTG PLC 631.00 GBp +8.50
Impax Laboratories Inc $42.40 USD -1.57
Integra LifeSciences Holdings Corp $60.79 USD +0.25
Krka dd Novo mesto €62.30 EUR +0.50
Richter Gedeon Nyrt 4,240 -20.00
View Industry Companies
 

Industry Analysis

MDCO

Industry Average

Valuation MDCO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.